|
1
|
Thompson RC, Swan SH, Moore CJ and vom
Saal FS: Our plastic age. Philos Trans R Soc Lond B Biol Sci.
364:1973–1976. 2009.PubMed/NCBI
|
|
2
|
Halden RU: Plastics and health risks. Annu
Rev Public Health. 31:179–194. 2010.PubMed/NCBI
|
|
3
|
Gore AC, Chappell VA, Fenton SE, Flaws JA,
Nadal A, Prins GS, Toppari J and Zoeller RT: Executive summary to
EDC-2: The endocrine society's second scientific statement on
endocrine-disrupting chemicals. Endocr Rev. 36:593–602.
2015.PubMed/NCBI
|
|
4
|
Rodriguez C, Patel AV, Calle EE, Jacob EJ
and Thun MJ: Estrogen replacement therapy and ovarian cancer
mortality in a large prospective study of US women. JAMA.
285:1460–1465. 2001.PubMed/NCBI
|
|
5
|
Dodds LW and Lawson W: Synthetic
estrogenic agents without the phenanthrene nucleus. Nature.
137:9961937.
|
|
6
|
Ding ZM, Jiao XF, Wu D, Zhang JY, Chen F,
Wang YS, Huang CJ, Zhang SX, Li X and Huo LJ: Bisphenol AF
negatively affects oocyte maturation of mouse in vitro through
increasing oxidative stress and DNA damage. Chem Biol Interact.
278:222–229. 2017.PubMed/NCBI
|
|
7
|
Geens T, Goeyens L and Covaci A: Are
potential sources for human exposure to bisphenol-A overlooked? Int
J Hyg Environ Health. 214:339–347. 2011.PubMed/NCBI
|
|
8
|
Vivacqua A, Recchia AG, Fasanella G,
Gabriele S, Carpino A, Rago V, Di Gioia ML, Leggio A, Bonofiglio D,
Liguori A, et al: The food contaminants bisphenol A and
4-nonylphenol act as agonists for estrogen receptor alpha in MCF7
breast cancer cells. Endocrine. 22:275–284. 2003.PubMed/NCBI
|
|
9
|
Geens T, Aerts D, Berthot C, Bourguignon
JP, Goeyens L, Lecomte P, Maghuin-Rogister G, Pironnet AM,
Pussemier L, Scippo ML, et al: A review of dietary and non-dietary
exposure to bisphenol-A. Food Chem Toxicol. 50:3725–3740.
2012.PubMed/NCBI
|
|
10
|
Konieczna A, Rutkowska A and Rachoń D:
Health risk of exposure to Bisphenol A (BPA). Rocz Panstw Zakl Hig.
66:5–11. 2015.PubMed/NCBI
|
|
11
|
Van Landuyt KL, Nawrot T, Geebelen B, De
Munck J, Snauwaert J, Yoshihara K, Scheers H, Godderis L, Hoet P
and Van Meerbeek B: How much do resin-based dental materials
release? A meta-analytical approach. Dent Mater. 27:723–747.
2011.PubMed/NCBI
|
|
12
|
Oldring PK, Castle L, O'Mahony C and Dixon
J: Estimates of dietary exposure to bisphenol A (BPA) from light
metal packaging using food consumption and packaging usage data: A
refined deterministic approach and a fully probabilistic (FACET)
approach. Food Addit Contam Part A Chem Anal Control Expo Risk
Assess. 31:466–489. 2014.PubMed/NCBI
|
|
13
|
Cao XL, Corriveau J and Popovic S:
Bisphenol a in canned food products from canadian markets. J Food
Prot. 73:1085–1089. 2010.PubMed/NCBI
|
|
14
|
Hanaoka T, Kawamura N, Hara K and Tsugane
S: Urinary bisphenol A and plasma hormone concentrations in male
workers exposed to bisphenol A diglycidyl ether and mixed organic
solvents. Occup Environ Med. 59:625–628. 2002.PubMed/NCBI
|
|
15
|
Calafat AM, Ye X, Wong LY, Reidy JA and
Needham LL: Exposure of the U.S. population to bisphenol A and
4-tertiary-octylphenol: 2003–2004. Environ Health Perspect.
116:39–44. 2008.PubMed/NCBI
|
|
16
|
Erler C and Novak J: Bisphenol a exposure:
Human risk and health policy. J Pediatr Nurs. 25:400–407.
2010.PubMed/NCBI
|
|
17
|
Zhang T, Sun H and Kannan K: Blood and
urinary bisphenol A concentrations in children, adults, and
pregnant women from china: Partitioning between blood and urine and
maternal and fetal cord blood. Environ Sci Technol. 47:4686–4694.
2013.PubMed/NCBI
|
|
18
|
Huang RP, Liu ZH, Yin H, Dang Z, Wu PX,
Zhu NW and Lin Z: Bisphenol A concentrations in human urine, human
intakes across six continents, and annual trends of average intakes
in adult and child populations worldwide: A thorough literature
review. Sci Total Environ. 626:971–981. 2018.PubMed/NCBI
|
|
19
|
Drozdz K, Wysokinski D, Krupa R and
Wozniak K: Bisphenol A-glycidyl methacrylate induces a broad
spectrum of DNA damage in human lymphocytes. Arch Toxicol.
85:1453–1461. 2011.PubMed/NCBI
|
|
20
|
Fleisch AF, Sheffield PE, Chinn C,
Edelstein BL and Landrigan PJ: Bisphenol A and related compounds in
dental materials. Pediatrics. 126:760–768. 2010.PubMed/NCBI
|
|
21
|
Dumitrascu MC, Iliescu M, Petca RC, Sandru
F, Mehedintu C, Farcasanu PD, Maru N, Chibelean C and Petca A: The
chemical pregnancy. Rev Chim. 70:3818–3823. 2019.
|
|
22
|
Ehrlich S, Williams PL, Missmer SA, Flaws
JA, Ye X, Calafat AM, Petrozza JC, Wright D and Hauser R: Urinary
bisphenol A concentrations and early reproductive health outcomes
among women undergoing IVF. Hum Reprod. 27:3583–3592.
2012.PubMed/NCBI
|
|
23
|
Petca A, Bot M, Petca RC, Mehedintu C,
Barac RI, Iliescu M, Maru N and Mastalier B: Chemicals in personal
care tied to early puberty in girls. Rev Chim. 70:3206–3209.
2019.
|
|
24
|
Fernández M, Bourguignon N, Lux-Lantos V
and Libertun C: Neonatal exposure to bisphenol a and reproductive
and endocrine alterations resembling the polycystic ovarian
syndrome in adult rats. Environ Health Perspect. 118:1217–1222.
2010.PubMed/NCBI
|
|
25
|
Cobellis L, Colacurci N, Trabucco E,
Carpentiero C and Grumetto L: Measurement of bisphenol A and
bisphenol B levels in human blood sera from healthy and
endometriotic women. Biomed Chromatogr. 23:1186–1190.
2009.PubMed/NCBI
|
|
26
|
Hoepner LA, Whyatt RM, Widen EM, Hassoun
A, Oberfield SE, Mueller NT, Diaz D, Calafat AM, Perera FP and
Rundle AG: Bisphenol A and Adiposity in an Inner-City Birth Cohort.
Environ Health Perspect. 124:1644–1650. 2016.PubMed/NCBI
|
|
27
|
Castoria G, Giovannelli P, Lombardi M, De
Rosa C, Giraldi T, de Falco A, Barone MV, Abbondanza C, Migliaccio
A and Auricchio F: Tyrosine phosphorylation of estradiol receptor
by Src regulates its hormone-dependent nuclear export and cell
cycle progression in breast cancer cells. Oncogene. 31:4868–4877.
2012.PubMed/NCBI
|
|
28
|
Mares C, Popescu R, Petca A, Maru N,
Dogaroiu C and Petca RC: Bisphenol-A and other plastics: Review of
endocrine disrupting effects on prostate cancer. Mater Plast.
57:239–252. 2020.
|
|
29
|
Lombardi M, Castoria G, Migliaccio A,
Barone MV, Di Stasio R, Ciociola A, Bottero D, Yamaguchi H, Appella
E and Auricchio F: Hormone-dependent nuclear export of estradiol
receptor and DNA synthesis in breast cancer cells. J Cell Biol.
182:327–340. 2008.PubMed/NCBI
|
|
30
|
Varricchio L, Migliaccio A, Castoria G,
Yamaguchi H, de Falco A, Di Domenico M, Giovannelli P, Farrar W,
Appella E and Auricchio F: Inhibition of estradiol receptor/Src
association and cell growth by an estradiol receptor alpha
tyrosine-phosphorylated peptide. Mol Cancer Res. 5:1213–1221.
2007.PubMed/NCBI
|
|
31
|
Rodríguez HA, Santambrosio N, Santamaría
CG, Muñoz-de-Toro M and Luque EH: Neonatal exposure to bisphenol A
reduces the pool of primordial follicles in the rat ovary. Reprod
Toxicol. 30:550–557. 2010.PubMed/NCBI
|
|
32
|
Markey CM, Coombs MA, Sonnenschein C and
Soto AM: Mammalian development in a changing environment: Exposure
to endocrine disruptors reveals the developmental plasticity of
steroid-hormone target organs. Evol Dev. 5:67–75. 2003.PubMed/NCBI
|
|
33
|
Hunt PA, Koehler KE, Susiarjo M, Hodges
CA, Ilagan A, Voigt RC, Thomas S, Thomas BF and Hassold TJ:
Bisphenol a exposure causes meiotic aneuploidy in the female mouse.
Curr Biol. 13:546–553. 2003.PubMed/NCBI
|
|
34
|
Mei L, Chen H, Wei DM, Fang F, Liu GJ, Xie
HY, Wang X, Zou J, Han X and Feng D: Maintenance chemotherapy for
ovarian cancer. Cochrane Database Syst Rev. 9:CD0074142010.
|
|
35
|
Petca A, Petca RC, Zvanca M, Maru N,
Mastalier B and Dogaroiu C: Fetal death from ruptured vasa previa:
A tragic event in the ultrasonographic era. Rom J Leg Med.
27:43–46. 2019.
|
|
36
|
Momenimovahed Z, Tiznobaik A, Taheri S and
Salehiniya H: Ovarian cancer in the world: Epidemiology and risk
factors. Int J Womens Health. 11:287–299. 2019.PubMed/NCBI
|
|
37
|
Dekant W and Völkel W: Human exposure to
bisphenol A by biomonitoring: Methods, results and assessment of
environmental exposures. Toxicol Appl Pharmacol. 228:114–134.
2008.PubMed/NCBI
|
|
38
|
Akahira J, Suzuki T, Ito K, Kaneko C,
Darnel AD, Moriya T, Okamura K, Yaegashi N and Sasano H:
Differential expression of progesterone receptor isoforms A and B
in the normal ovary, and in benign, borderline, and malignant
ovarian tumors. Jpn J Cancer Res. 93:807–815. 2002.PubMed/NCBI
|
|
39
|
Newbold RR, Jefferson WN and Padilla-Banks
E: Long-term adverse effects of neonatal exposure to bisphenol A on
the murine female reproductive tract. Reprod Toxicol. 24:253–258.
2007.PubMed/NCBI
|
|
40
|
Enmark E, Pelto-Huikko M, Grandien K,
Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M and
Gustafsson JA: Human estrogen receptor beta-gene structure,
chromosomal localization, and expression pattern. J Clin Endocrinol
Metab. 82:4258–4265. 1997.PubMed/NCBI
|
|
41
|
Kuiper GG and Gustafsson JA: The novel
estrogen receptor-beta subtype: Potential role in the cell- and
promoter-specific actions of estrogens and anti-estrogens. FEBS
Lett. 410:87–90. 1997.PubMed/NCBI
|
|
42
|
Pujol P, Rey JM, Nirde P, Roger P,
Gastaldi M, Laffargue F, Rochefort H and Maudelonde T: Differential
expression of estrogen receptor-α and -β messenger RNAs as a
potential marker of ovarian carcinogenesis. Cancer Res.
58:5367–5373. 1998.PubMed/NCBI
|
|
43
|
Bardin A, Hoffmann P, Boulle N, Katsaros
D, Vignon F, Pujol P and Lazennec G: Involvement of estrogen
receptor beta in ovarian carcinogenesis. Cancer Res. 64:5861–5869.
2004.PubMed/NCBI
|
|
44
|
Hua H, Zhang H, Kong Q and Jiang Y:
Mechanisms for estrogen receptor expression in human cancer. Exp
Hematol Oncol. 7:242018.PubMed/NCBI
|
|
45
|
Münstedt K, Steen J, Knauf AG, Buch T, von
Georgi R and Franke FE: Steroid hormone receptors and long term
survival in invasive ovarian cancer. Cancer. 89:1783–1791.
2000.PubMed/NCBI
|
|
46
|
Bai W, Oliveros-Saunders B, Wang Q,
Acevedo-Duncan ME and Nicosia SV: Estrogen stimulation of ovarian
surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim.
36:657–666. 2000.PubMed/NCBI
|
|
47
|
O'Donnell AJ, Macleod KG, Burns DJ, Smyth
JF and Langdon SP: Estrogen receptor-alpha mediates gene expression
changes and growth response in ovarian cancer cells exposed to
estrogen. Endocr Relat Cancer. 12:851–866. 2005.PubMed/NCBI
|
|
48
|
Riman T, Dickman PW, Nilsson S, Correia N,
Nordlinder H, Magnusson CM, Weiderpass E and Persson IR: Hormone
replacement therapy and the risk of invasive epithelial ovarian
cancer in Swedish women. J Natl Cancer Inst. 94:497–504.
2002.PubMed/NCBI
|
|
49
|
Lacey JV Jr, Mink PJ, Lubin JH, Sherman
ME, Troisi R, Hartge P, Schatzkin A and Schairer C: Menopausal
hormone replacement therapy and risk of ovarian cancer. JAMA.
288:334–341. 2002.PubMed/NCBI
|
|
50
|
Suzuki A, Sugihara A, Uchida K, Sato T,
Ohta Y, Katsu Y, Watanabe H and Iguchi T: Developmental effects of
perinatal exposure to bisphenol-A and diethylstilbestrol on
reproductive organs in female mice. Reprod Toxicol. 16:107–116.
2002.PubMed/NCBI
|
|
51
|
Ptak A, Wróbel A and Gregoraszczuk EL:
Effect of bisphenol-A on the expression of selected genes involved
in cell cycle and apoptosis in the OVCAR-3 cell line. Toxicol Lett.
202:30–35. 2011.PubMed/NCBI
|
|
52
|
Ptak A and Gregoraszczuk EL: Bisphenol A
induces leptin receptor expression, creating more binding sites for
leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt
signalling pathways in human ovarian cancer cell. Toxicol Lett.
210:332–337. 2012.PubMed/NCBI
|
|
53
|
Bredhult C, Bäcklin BM and Olovsson M:
Effects of some endocrine disruptors on the proliferation and
viability of human endometrial endothelial cells in vitro. Reprod
Toxicol. 23:550–559. 2007.PubMed/NCBI
|
|
54
|
Hall JM and Korach KS: Endocrine
disrupting chemicals promote the growth of ovarian cancer cells via
the ER-CXCL12-CXCR4 signaling axis. Mol Carcinog. 52:715–725.
2013.PubMed/NCBI
|
|
55
|
Cavallaro U and Christofori G:
Multitasking in tumor progression: Signaling functions of cell
adhesion molecules. Ann N Y Acad Sci. 1014:58–66. 2004.PubMed/NCBI
|
|
56
|
Lengyel E: Ovarian cancer development and
metastasis. Am J Pathol. 177:1053–1064. 2010.PubMed/NCBI
|
|
57
|
Hazan RB, Phillips GR, Qiao RF, Norton L
and Aaronson SA: Exogenous expression of N-cadherin in breast
cancer cells induces cell migration, invasion, and metastasis. J
Cell Biol. 148:779–790. 2000.PubMed/NCBI
|
|
58
|
Hudson LG, Zeineldin R and Stack MS:
Phenotypic plasticity of neoplastic ovarian epithelium: Unique
cadherin profiles in tumor progression. Clin Exp Metastasis.
25:643–655. 2008.PubMed/NCBI
|
|
59
|
Davidson B, Goldberg I, Gotlieb WH,
Kopolovic J, Ben-Baruch G, Nesland JM and Reich R: The prognostic
value of metalloproteinases and angiogenic factors in ovarian
carcinoma. Mol Cell Endocrinol. 187:39–45. 2002.PubMed/NCBI
|
|
60
|
Kenny HA and Lengyel E: MMP-2 functions as
an early response protein in ovarian cancer metastasis. Cell Cycle.
8:683–688. 2009.PubMed/NCBI
|
|
61
|
Symowicz J, Adley BP, Gleason KJ, Johnson
JJ, Ghosh S, Fishman DA, Hudson LG and Stack MS: Engagement of
collagen-binding integrins promotes matrix
metalloproteinase-9-dependent E-cadherin ectodomain shedding in
ovarian carcinoma cells. Cancer Res. 67:2030–2039. 2007.PubMed/NCBI
|
|
62
|
Kim JY, Yi BR, Go RE, Hwang KA, Nam KH and
Choi KC: Methoxychlor and triclosan stimulates ovarian cancer
growth by regulating cell cycle- and apoptosis-related genes via an
estrogen receptor-dependent pathway. Environ Toxicol Pharmacol.
37:1264–1274. 2014.PubMed/NCBI
|
|
63
|
Teilmann G, Juul A, Skakkebaek NE and
Toppari J: Putative effects of endocrine disrupters on pubertal
development in the human. Best Pract Res Clin Endocrinol Metab.
16:105–121. 2002.PubMed/NCBI
|
|
64
|
Fenichel P, Chevalier N and Brucker-Davis
F: Bisphenol A: An endocrine and metabolic disruptor. Ann
Endocrinol (Paris). 74:211–220. 2013.PubMed/NCBI
|
|
65
|
Chibelean CB, Petca RC, Radu DC and Petca
A: State of the art in fertility preservation for female patients
prior to oncologic therapies. Medicina (Kaunas). 56:892020.
|
|
66
|
Tsuda H, Naito A, Kim CK, Fukamachi K,
Nomoto H and Moore MA: Carcinogenesis and its modification by
environmental endocrine disruptors: In vivo experimental and
epidemiological findings. Jpn J Clin Oncol. 33:259–270.
2003.PubMed/NCBI
|
|
67
|
Fenton SE: Endocrine-disrupting compounds
and mammary gland development: Early exposure and later life
consequences. Endocrinology. 147 (Suppl):S18–S24. 2006.PubMed/NCBI
|
|
68
|
Fernandez SV and Russo J: Estrogen and
xenoestrogens in breast cancer. Toxicol Pathol. 38:110–122.
2010.PubMed/NCBI
|
|
69
|
Wetherill YB, Akingbemi BT, Kanno J,
McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT and
Belcher SM: In vitro molecular mechanisms of bisphenol A action.
Reprod Toxicol. 24:178–198. 2007.PubMed/NCBI
|
|
70
|
Tharp AP, Maffini MV, Hunt PA, VandeVoort
CA, Sonnenschein C and Soto AM: Bisphenol A alters the development
of the rhesus monkey mammary gland. Proc Natl Acad Sci USA.
109:8190–8195. 2012.PubMed/NCBI
|
|
71
|
Murray TJ, Maffini MV, Ucci AA,
Sonnenschein C and Soto AM: Induction of mammary gland ductal
hyperplasias and carcinoma in situ following fetal bisphenol A
exposure. Reprod Toxicol. 23:383–390. 2007.PubMed/NCBI
|
|
72
|
Acevedo N, Davis B, Schaeberle CM,
Sonnenschein C and Soto AM: Perinatally administered bisphenol a as
a potential mammary gland carcinogen in rats. Environ Health
Perspect. 121:1040–1046. 2013.PubMed/NCBI
|
|
73
|
Hofseth LJ, Raafat AM, Osuch JR, Pathak
DR, Slomski CA and Haslam SZ: Hormone replacement therapy with
estrogen or estrogen plus medroxyprogesterone acetate is associated
with increased epithelial proliferation in the normal
postmenopausal breast. J Clin Endocrinol Metab. 84:4559–4565.
1999.PubMed/NCBI
|
|
74
|
Santen RJ and Harvey HA: Use of aromatase
inhibitors in breast carcinoma. Endocr Relat Cancer. 6:75–92.
1999.PubMed/NCBI
|
|
75
|
Zgura A, Gales L, Haineala B, Bratila E,
Mehedintu C, Andreescu CV, Berceanu C, Petca A, Barac RI, Ionescu
A, et al: Correlations between known prognostic markers and tumor -
infiltrating lymphocytes in breast cancer. Rev Chim. 70:2362–2366.
2019.
|
|
76
|
Migliaccio A, Castoria G and Auricchio F:
Src-dependent signalling pathway regulation by sex-steroid
hormones: Therapeutic implications. Int J Biochem Cell Biol.
39:1343–1348. 2007.PubMed/NCBI
|
|
77
|
Castoria G, Migliaccio A, Di Domenico M,
Lombardi M, de Falco A, Varricchio L, Bilancio A, Barone MV and
Auricchio F: Role of atypical protein kinase C in
estradiol-triggered G1/S progression of MCF-7 cells. Mol Cell Biol.
24:7643–7653. 2004.PubMed/NCBI
|
|
78
|
Foulkes WD: Inherited susceptibility to
common cancers. N Engl J Med. 359:2143–2153. 2008.PubMed/NCBI
|
|
79
|
Fernandez SV, Huang Y, Snider KE, Zhou Y,
Pogash TJ and Russo J: Expression and DNA methylation changes in
human breast epithelial cells after bisphenol A exposure. Int J
Oncol. 41:369–377. 2012.PubMed/NCBI
|
|
80
|
Jung JW, Park SB, Lee SJ, Seo MS, Trosko
JE and Kang KS: Metformin represses self-renewal of the human
breast carcinoma stem cells via inhibition of estrogen
receptor-mediated OCT4 expression. PLoS One.
6:e280682011.PubMed/NCBI
|
|
81
|
Rathore A, Ranjan S and Dubey AP:
Hereditary breast-ovarian cancer syndrome. Cancer Res Stat Treat.
3:374–375. 2020.
|
|
82
|
Lapensee EW, Tuttle TR, Fox SR and
Ben-Jonathan N: Bisphenol A at low nanomolar doses confers
chemoresistance in estrogen receptor-alpha-positive and -negative
breast cancer cells. Environ Health Perspect. 117:175–180.
2009.PubMed/NCBI
|
|
83
|
Dairkee SH, Luciani-Torres MG, Moore DH
and Goodson WH III: Bisphenol-A-induced inactivation of the p53
axis underlying deregulation of proliferation kinetics, and cell
death in non-malignant human breast epithelial cells.
Carcinogenesis. 34:703–712. 2013.PubMed/NCBI
|
|
84
|
Zhang W, Fang Y, Shi X, Zhang M, Wang X
and Tan Y: Effect of bisphenol A on the EGFR-STAT3 pathway in MCF-7
breast cancer cells. Mol Med Rep. 5:41–47. 2012.PubMed/NCBI
|
|
85
|
Buteau-Lozano H, Velasco G, Cristofari M,
Balaguer P and Perrot-Applanat M: Xenoestrogens modulate vascular
endothelial growth factor secretion in breast cancer cells through
an estrogen receptor-dependent mechanism. J Endocrinol.
196:399–412. 2008.PubMed/NCBI
|
|
86
|
Dong S, Terasaka S and Kiyama R: Bisphenol
A induces a rapid activation of Erk1/2 through GPR30 in human
breast cancer cells. Environ Pollut. 159:212–218. 2011.PubMed/NCBI
|
|
87
|
Radice S, Chiesara E, Fucile S and
Marabini L: Different effects of PCB101, PCB118, PCB138 and PCB153
alone or mixed in MCF-7 breast cancer cells. Food Chem Toxicol.
46:2561–2567. 2008.PubMed/NCBI
|
|
88
|
Parada H Jr, Wolff MS, Engel LS, Eng SM,
Khankari NK, Neugut AI, Teitelbaum SL and Gammon MD:
Polychlorinated biphenyls and their association with survival
following breast cancer. Eur J Cancer. 56:21–30. 2016.PubMed/NCBI
|
|
89
|
Combarnous Y and Nguyen TMD: Comparative
overview of the mechanisms of action of hormones and endocrine
disruptor compounds. Toxics. 7:52019.
|
|
90
|
Nagel SC and Bromfield JJ: Bisphenol a: A
model endocrine disrupting chemical with a new potential mechanism
of action. Endocrinology. 154:1962–1964. 2013.PubMed/NCBI
|
|
91
|
Li L, Wang Q, Zhang Y, Niu Y, Yao X and
Liu H: The molecular mechanism of bisphenol A (BPA) as an endocrine
disruptor by interacting with nuclear receptors: Insights from
molecular dynamics (MD) simulations. PLoS One.
10:e01203302015.PubMed/NCBI
|
|
92
|
Acconcia F, Pallottini V and Marino M:
Molecular mechanisms of action of BPA. Dose Response.
13:15593258156105822015.PubMed/NCBI
|
|
93
|
Paterni I, Granchi C and Minutolo F: Risks
and benefits related to alimentary exposure to xenoestrogens. Crit
Rev Food Sci Nutr. 57:3384–3404. 2017.PubMed/NCBI
|
|
94
|
Caserta D, Di Segni N, Mallozzi M,
Giovanale V, Mantovani A, Marci R and Moscarini M: Bisphenol A and
the female reproductive tract: An overview of recent laboratory
evidence and epidemiological studies. Reprod Biol Endocrinol.
12:372014.PubMed/NCBI
|
|
95
|
Hui L, Li H, Lu G, Chen Z, Sun W, Shi Y,
Fu Z, Huang B, Zhu X, Lu W, et al: Low dose of bisphenol a
modulates ovarian cancer gene expression profile and promotes
epithelial to mesenchymal transition via canonical wnt pathway.
Toxicol Sci. 164:527–538. 2018.PubMed/NCBI
|
|
96
|
Weber Lozada K and Keri RA: Bisphenol A
increases mammary cancer risk in two distinct mouse models of
breast cancer. Biol Reprod. 85:490–497. 2011.PubMed/NCBI
|
|
97
|
Seachrist DD, Bonk KW, Ho SM, Prins GS,
Soto AM and Keri RA: A review of the carcinogenic potential of
bisphenol A. Reprod Toxicol. 59:167–182. 2016.PubMed/NCBI
|
|
98
|
Caporossi L and Papaleo B: Exposure to
Bisphenol A and gender differences: From rodents to humans
evidences and hypothesis about the health effects. J Xenobiot.
5:52642015.PubMed/NCBI
|
